Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of High-Dose Allovectin-7® in Patients With Advanced Metastatic Melanoma

NCT00044356 is registered in ClinicalTrials.gov with Vical as lead sponsor.

NCT NCT00044356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00044356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of High-Dose Allovectin-7® in Patients With Advanced Metastatic Melanoma
Lead sponsor
Vical
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2001
Completion date
September 30, 2004
Enrollment
133 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma, melanoma, metastatic melanoma, skin cancer